Company / Interest Expense
Silo Pharma, Inc. Interest Expense History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.2K
FY2023
5-year range
$0 / $62.7K
FY2019-FY2023
Trend
-
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $62,739 to $2,199 over the past 4 years.
Based on SEC 10-K filings.
$2,199 in FY2023.
Improved from $62,739 to $2,199 over the past 4 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $2.2K | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $62.7K | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026